Canaccord Genuity Maintains Buy on Stryker, Lowers Price Target to $385

Benzinga · 1d ago
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $400 to $385.